| |
| |
|
| Insider
Information: |
Lawrence David |
| Relationship: |
Chief, Bus. Ops & PAO |
| City: |
Hawthorne |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
13,811 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,933 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,811 |
|
|
| Total
Value |
$6,933 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Chief, Bus. Ops & PAO |
2020-12-01 |
13,811 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-03-10 |
4 |
OE |
$8.14 |
$97,680 |
D/D |
12,000 |
22,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2012-12-07 |
4 |
OE |
$5.85 |
$6 |
D/D |
1 |
17,937 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2014-12-18 |
4 |
OE |
$8.14 |
$220,667 |
D/D |
27,109 |
38,155 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2015-12-18 |
4 |
OE |
$5.85 |
$230,931 |
D/D |
39,026 |
48,228 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief of Business Operations |
• – – |
2016-06-22 |
4 |
OE |
$8.50 |
$4,250 |
D/D |
500 |
9,702 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2017-02-09 |
4 |
OE |
$22.13 |
$1,398,240 |
D/D |
63,183 |
67,719 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-01-18 |
4 |
OE |
$19.81 |
$11,529 |
D/D |
582 |
5,275 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-01-19 |
4 |
OE |
$19.81 |
$602,581 |
D/D |
30,418 |
35,111 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-06-07 |
4 |
OE |
$20.59 |
$409,329 |
D/D |
19,880 |
28,004 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2018-06-08 |
4 |
OE |
$20.59 |
$105,421 |
D/D |
5,120 |
13,244 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-03-22 |
4/A |
S |
$19.55 |
$116,622 |
D/D |
(5,941) |
17,825 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2007-06-15 |
4 |
S |
$18.48 |
$37,087 |
D/D |
(2,007) |
14,052 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-04 |
4 |
S |
$29.76 |
$357,873 |
D/D |
(12,000) |
12,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-04 |
4 |
S |
$29.39 |
$623,425 |
D/D |
(21,106) |
24,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2008-06-12 |
4 |
S |
$21.67 |
$218,622 |
D/D |
(7,000) |
12,400 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief Financial Officer |
• – – |
2010-03-10 |
4 |
S |
$34.16 |
$409,961 |
D/D |
(12,000) |
10,800 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Chief, Bus. Ops & PAO |
• – – |
2019-02-22 |
4 |
S |
$13.18 |
$10,028 |
D/D |
(761) |
5,092 |
0 |
- |
|
92 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
